Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

Antiseptic mouthwash reduces periodontitis bacteria in diabetes patients

More than bad breath, there is growing evidence that ongoing inflammation in the mouth, like with gum disease, is associated with serious diseases such as Alzheimer's disease or type 2 diabetes.

14 Feb 2024

Neural prosthetic device successfully used to recall specific memories

A team of scientists from Wake Forest University School of Medicine and the University of Southern California (USC) have demonstrated the first successful use of a neural prosthetic device to recall specific memories.

13 Feb 2024

Scientists discover how oxytocin influences memory in animals

Oxytocin (OXT) is a hormone that is known for its effects on psychological well-being and emotional bonding in animals.

13 Feb 2024

Diabetes management program cuts dementia risk in type 2 patients

A recent study highlights the effectiveness of a multidisciplinary diabetes management program in reducing the risk of dementia in type 2 diabetes patients, emphasizing the importance of glycemic control for dementia prevention.

13 Feb 2024

Glial fibrillary acidic protein levels pinpoint future dementia risk a decade in advance

Researchers identify GFAP as a potent biomarker for predicting dementia risk over a decade before clinical diagnosis, underscoring its potential for early screening and intervention in asymptomatic individuals.

13 Feb 2024

A century of progress: American Heart Association's historic journey and future directions

Dramatic advances in the understanding and treatment of cardiovascular diseases have saved millions of lives in the 100 years since the founding in 1924 of the American Heart Association, the world's leading voluntary organization focused on heart and brain health for all.

13 Feb 2024

Proteomic biomarkers in blood plasma as predictors of dementia in healthy individuals

The predictive power of plasma proteomic profiles for future dementia onset in adults without dementia.

13 Feb 2024

Daily aspirin linked to higher mortality in older adults, study finds

A study from the ASPREE clinical trial found that daily aspirin intake in adults over 70 did not increase disability-free survival and was associated with higher all-cause mortality, primarily due to cancer-related deaths.

12 Feb 2024

Olive oil's secret weapon against Alzheimer's: phenolic compounds

A comprehensive review in the International Journal of Molecular Sciences highlights the potential of extra-virgin olive oil and its phenolic compounds in preventing and treating Alzheimer's disease through various mechanisms, including reducing amyloid-beta accumulation and neuroinflammation.

12 Feb 2024

Complications during pregnancy linked to higher risk of heart disease and stroke later in life

Heart disease is the leading cause of death among women, and women who have complications during pregnancy, such as high blood pressure or gestational diabetes, have a significantly higher risk of heart disease and stroke later in life, according to a new scientific statement from the American Heart Association, published today in Circulation, the Association's flagship peer-reviewed journal.

12 Feb 2024

Study finds erectile dysfunction drugs linked to lower Alzheimer's risk

Researchers evaluated the effect of phosphodiesterase-5 inhibitor (PDE5I) initiation compared to non-use and Alzheimer's disease development risk among males suffering from erectile dysfunction.

12 Feb 2024

Unlocking Alzheimer's secrets: Study pinpoints APOE4's harmful effect on lipids

UNC School of Medicine researcher Sarah Cohen, PhD, and Ian Windham, a former PhD student from the Cohen lab, have made a new discovery about apolipoprotein E (APOE) – the biggest genetic risk factor for late-onset Alzheimer's disease.

9 Feb 2024

UH Brain Health & Memory Center now treating patients with FDA-approved drug for Alzheimer's disease

University Hospitals (UH) Brain Health & Memory Center is now treating patients with LEQEMBI (lecanemab), a Food and Drug Administration-approved medication for the treatment of Alzheimer's disease.

9 Feb 2024

Immune system in the blood of Alzheimer's patients found to be epigenetically altered

A new Northwestern Medicine study has found the immune system in the blood of Alzheimer's patients is epigenetically altered.

9 Feb 2024

Men using erectile dysfunction drugs less likely to develop Alzheimer's disease

Drugs commonly used to treat erectile dysfunction may reduce the risk of Alzheimer's disease, finds a new study led by UCL researchers.

9 Feb 2024

Older Asian Americans hesitant to participate in MRI research, study finds

Asian Americans are less likely than their white peers to participate in health research involving MRIs and addressing this hesitancy could improve research, according to a Rutgers Health-led study.

9 Feb 2024

Do we simply not care about old people?

The covid-19 pandemic would be a wake-up call for America, advocates for the elderly predicted: incontrovertible proof that the nation wasn't doing enough to care for vulnerable older adults.

9 Feb 2024

COVID-19 linked to higher dementia risk in older adults, study finds

Research indicates a potential link between COVID-19 and an increased risk of new-onset dementia in adults over 60, with the risk being similar to that from other respiratory infections.

9 Feb 2024

Immigrants with dementia more likely to present with agitation or aggression, study finds

Immigrants living with dementia were more likely to present with agitation and aggression compared with their non-immigrant counterparts, a new study by Edith Cowan University (ECU) in collaboration with The Dementia Centre, HammondCare, found.

8 Feb 2024

Multi-level network analysis provides integrated view of multiple sclerosis

International research led by the Department of Medicine and Life Sciences (MELIS) at Pompeu Fabra University, in collaboration with Hospital del Mar, Hospital Clínic, Charité - Medical University of Berlin, and the universities of Oslo and Genoa, has developed a computational biology tool, based on multi-level network analysis, to achieve an integrated vision of multiple sclerosis.

8 Feb 2024